American Heart Journal
Volume 143, Issue 6 , Pages 11-14 , June 2002

No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy

Received 6 August 2001 ,Accepted 20 November 2001.

References 

  1. Richardson P, McKenna W, Bristow M, et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841–842
  2. Maron BJ, Bonow RO, Cannon RO, et al.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316(1):780–789
  3. Maron BJ, Bonow RO, Cannon RO, et al.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316(2):844–852
  4. Keeling PJ, Gang Y, Smith G, et al.  Familial dilated cardiomyopathy in the United Kingdom. Br Heart J. 1995;73:417–421
  5. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001;33:655–670
  6. Towbin JA. Pediatric myocardial disease. Pediatr Clin North Am. 1999;46:289–312
  7. Watkins H, Thierfelder L, Hwang DS, et al.  Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest. 1992;90:1666–1671
  8. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006
  9. Thierfelder L, Watkins H, MacRae C, et al.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell. 1994;77:701–712
  10. Watkins H, McKenna WJ, Thierfelder L, et al.  Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058–1064
  11. Bonne G, Carrier L, Bercovici J, et al.  Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:438–440
  12. Poetter K, Jiang H, Hassanzadeh S, et al.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat Genet. 1996;13:63–69
  13. Kimura A, Harada H, Park JE, et al.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet. 1997;16:379–382
  14. Mörner S, Richard P, Kazzam E, et al.  Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2000;32:521–525
  15. Mogensen J, Klausen IC, Pedersen AK, et al.  Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J Clin Invest. 1999;103:R39–R43
  16. Satoh M, Takahashi M, Sakamoto T, et al.  Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem Biophys Res Commun. 1999;262:411–417
  17. Blair E, Redwood C, Ashrafian H, et al.  Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. Hum Mol Genet. 2001;10:1215–1220
  18. Olson TM, Kishimoto NY, Whitby FG, et al.  Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol. 2001;33:723–732
  19. Towbin JA, Hejtmancik JF, Brink P, et al.  X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854–1865
  20. Muntoni F, Cau M, Ganau A, et al.  Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921–925
  21. Ortiz-Lopez R, Li H, Su J, et al.  Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy. Circulation. 1997;95:2434–2440
  22. Olson TM, Michels VV, Thibodeau SN, et al.  Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998;280:750–752
  23. Li D, Tapscoft T, Gonzalez O, et al.  Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation. 1999;100:461–464
  24. Tsubata S, Bowles KR, Vatta M, et al.  Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest. 2000;106:655–662
  25. Kamisago M, Sharma SD, DePalma SR, et al.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med. 2000;343:1688–1696
  26. Durand JB, Bachinski LL, Bieling LC, et al.  Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation. 1995;92:3387–3389
  27. Siu BL, Niimura H, Osborne JA, et al.  Familial dilated cardiomyopathy locus maps to chromosome 2q31. Circulation. 1999;99:1022–1026
  28. Krajinovic M, Pinamonti B, Sinagra G, et al.  Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group. Am J Hum Genet. 1995;57:846–852
  29. Jung M, Poepping I, Perrot A, et al.  Investigation of a family with autosomal dominant dilated cardiomyopathy defines a novel locus on chromosome 2q14-q22. Am J Hum Genet. 1999;65:1068–1077
  30. Bowles KR, Gajarski R, Porter P, et al.  Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest. 1996;98:1355–1360
  31. Messina DN, Speer MC, Pericak-Vance MA, et al.  Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet. 1997;61:909–917
  32. Olson TM, Keating MT. Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest. 1996;97:528–532
  33. Kass S, MacRae C, Graber HL, et al.  A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet. 1994;7:546–551
  34. Sylvius N, Tesson F, Gayet C, et al.  A new locus for autosomal dominant dilated cardiomyopathy identified on chromosome 6q12-q16. Am J Hum Genet. 2001;68:241–246
  35. Tesson F, Sylvius N, Pilotto A, et al.  Epidemiology of desmin and cardiac actin gene mutations in a European population of dilated cardiomyopathy. Eur Heart J. 2000;21:1872–1876
  36. Manolio TA, Baughman KL, Rodeheffer R, et al.  Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop). Am J Cardiol. 1992;69:1458–1466
  37. Orita M, Iwahana H, Kanazawa H, et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A. 1989;86:2766–2770
  38. Olson TM, Doan TP, Kishimoto NY, et al.  Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2000;32:1687–1694
  39. Takai E, Akita H, Shiga N, et al.  Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am J Med Genet. 1999;86:325–327
  40. Mayosi BM, Khogali S, Zhang B, et al.  Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet. 1999;36:796–797

☆ Reprint requests: Keijo Peuhkurinen, MD, PhD, Professor Department of Medicine, Kuopio University Hospital, PO Box 1777, 70211 Kuopio, Finland.

☆☆ E-mail: Keijo.Peuhkurinen@kuh.fi

PII: S0002-8703(02)00028-5

doi: 10.1067/mhj.2002.122514

American Heart Journal
Volume 143, Issue 6 , Pages 11-14 , June 2002

Article Tools